Suppr超能文献

立体定向放射外科治疗侵袭海绵窦的垂体腺瘤。

Stereotactic radiosurgery for pituitary adenoma invading the cavernous sinus.

作者信息

Shin M, Kurita H, Sasaki T, Tago M, Morita A, Ueki K, Kirino T

机构信息

Department of Neurosurgery, The University of Tokyo Hospital, Japan.

出版信息

J Neurosurg. 2000 Dec;93 Suppl 3:2-5. doi: 10.3171/jns.2000.93.supplement.

Abstract

OBJECT

The purpose of this study is to determine the efficacy of gamma knife radiosurgery (GKS) treatment of pituitary adenomas that have invaded the cavernous sinus.

METHODS

Sixteen patients were treated with GKS: three with nonfunctional adenomas and 13 with hormone-secreting (seven growth hormone [GH] and six adrenocorticotropic hormone [ACTH]) adenomas. More than 16 Gy and 30 Gy were delivered to the tumor margin for nonfunctioning tumors and functioning tumors, respectively, keeping the dose to the optic pathways below 10 Gy. The median follow up was 3 years. Tumor growth control was achieved in all cases. In GH-producing tumors, four of six cases evaluated were endocrinologically normalized (serum GH < 10 mIU/L, somatomedin C < 450 ng/ml), and the remaining two cases also showed a steady decrease in the GH and somatomedin level. In ACTH-producing tumors, three of six cases were endocrinologically normalized (24-hour urinary-free cortisol < 90 mg/day), two were unchanged, and one showed hormonal recurrence 3 years after radiosurgery. Notably, there were no cases of permanent hypopituitarism or visual symptoms caused by radiosurgery.

CONCLUSIONS

The authors data indicate that GKS can be a safe salvage therapy for invading pituitary adenomas, with effectiveness equivalent to conventional radiation therapy but with less risk of causing radiation-induced injury to the surrounding structures.

摘要

目的

本研究旨在确定伽玛刀放射外科治疗(GKS)侵袭海绵窦的垂体腺瘤的疗效。

方法

16例患者接受了GKS治疗:3例为无功能腺瘤,13例为分泌激素(7例生长激素[GH]和6例促肾上腺皮质激素[ACTH])腺瘤。无功能肿瘤和功能性肿瘤的肿瘤边缘分别给予超过16 Gy和30 Gy的剂量,同时将视路剂量保持在10 Gy以下。中位随访时间为3年。所有病例均实现了肿瘤生长控制。在分泌GH的肿瘤中,评估的6例中有4例内分泌功能恢复正常(血清GH<10 mIU/L,生长调节素C<450 ng/ml),其余2例的GH和生长调节素水平也呈稳步下降。在分泌ACTH的肿瘤中,6例中有3例内分泌功能恢复正常(24小时尿游离皮质醇<90 mg/天),2例无变化,1例在放射外科治疗3年后出现激素复发。值得注意的是,没有因放射外科治疗导致永久性垂体功能减退或视觉症状的病例。

结论

作者的数据表明,GKS可以作为侵袭性垂体腺瘤的一种安全的挽救性治疗方法,其有效性与传统放射治疗相当,但对周围结构造成放射性损伤的风险较小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验